Glaucoma may be a result of two pressures: IOP and intracranial pressure. When one pressure is high and the other is low, it results in ganglion cell proptosis, leading to glaucoma. KOLOA ...
with one end of the glass plumbing being fit to a total consumption spray chamber and the other end being fit to an ICP torch. The researchers found that the cell transport efficiency increased ...
Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...
NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results